| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |